Clinical Site Partners, LLC | Florida Pulmonary Research Institute, LLC
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Clinical Site Partners, LLC
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus pla...
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of m...
The purpose of this first-in-human study is to evaluate the safety and immunogenicity of mRNA-1468.
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...
The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and e...
A randomized, observer-blind, placebo-controlled immuno-bridging, and broadening study to demonstrate the equivalence of the immune response between...
Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...
Trial sponsors
Clinical trials
Research sites
Resources
Legal